Prescribing Information
MR Suite icon

Contact a
Sales Specialist

Thank you for your interest in Vueway™ (gadopiclenol) solution for injection, 485.1 mg/mL. Let’s connect today.
Fields marked with an * are required.

Thank you for signing up for updates!

We are honored that you’ve chosen to receive MRI updates from Bracco and can’t wait to share our news with you. We look forward to being in touch again soon.

Customer Service
IMPORTANT SAFETY INFORMATION  |  INDICATIONS AND USAGE

VUEWAY™ (gadopiclenol) solution for injection

IMPORTANT SAFETY INFORMATION

WARNING: NEPHROGENIC SYSTEMIC FIBROSIS (NSF)

Gadolinium-based contrast agents (GBCAs) increase the risk for NSF among patients with impaired elimination of the drugs. Avoid use of GBCAs in these patients unless the diagnostic information is essential and not available with non-contrasted MRI or other modalities. NSF may result in fatal or debilitating fibrosis affecting the skin, muscle and internal organs.